Literature DB >> 6787072

Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

A L Barry, C Thornsberry, R N Jones.   

Abstract

With currently recommended disk susceptibility tests, minimal inhibitory concentration correlates for amikacin were greater than 16 micrograms/ml for resistance and less than or equal to 12 micrograms/ml (not less than or equal to 8 micrograms/ml) for susceptibility. For gentamicin, they were greater than 8 micrograms/ml for resistance and less than or equal to 6 micrograms/ml (not less than or equal to 4 micrograms/ml) for susceptibility. Minor discrepancies between disk tests and minimal inhibitory concentration determinations will occur if only doubling dilutions of drug are used for measuring minimal inhibitory concentration values.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787072      PMCID: PMC273933          DOI: 10.1128/jcm.13.5.1000-1003.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.

Authors:  R C Moellering; C Wennersten; L J Kunz; J W Poitras
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

2.  Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.

Authors:  J A Washington; P K Yu; T L Gavan; F D Schoenknecht; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

3.  Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

Authors:  L B Reller; F D Schoenknecht; M A Kenny; J C Sherris
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

4.  Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.

Authors:  B H Minshew; H M Pollock; F D Schoenknecht; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

5.  Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.

Authors:  A L Barry; C Thornsberry; R N Jones; E H Gerlach
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.

Authors:  H M Pollock; B H Minshew; M A Kenny; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

  6 in total
  11 in total

1.  Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin.

Authors:  B F Woolfrey; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

2.  Susceptibility testing of multidrug-resistant Staphylococcus aureus with the Sceptor microdilution system.

Authors:  H C Blair; T J Cleary
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

3.  Pseudomonas aeruginosa ATCC 49189, a new quality control strain for testing P. aeruginosa susceptibility to the aminoglycosides.

Authors:  R T Lally; B F Woolfrey; M A Enright
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

4.  Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.

Authors:  A L Barry; G H Miller; R S Hare; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

5.  Proposed zone standards for interpretation of fortimicin A disk diffusion tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

6.  Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.

Authors:  B F Woolfrey; J M Fox; C O Quall; R T Lally
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; J Downes; K Stockman; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

8.  3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.

Authors:  A L Barry; R N Jones; C Thornsberry; T L Gavan; E H Gerlach; H M Sommer
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

9.  Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing.

Authors:  G Kronvall
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

10.  Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments.

Authors:  B F Woolfrey; J M Fox; R T Lally; C O Quall
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.